Spring 2011 Volume 8, Issue 7
Myeloma Today Spring 2011
* ASH 2010 Summary of Multiple Myeloma Presentations
* Velcade® by Subcutaneous Injection
IMF Hotline Coordinators Answer Your Questions: "My mother is 82 and fragile, and has been having trouble tolerating her myeloma treatments. Should we just give up on treatment altogether, or is there some way we can make the treatments more tolerable?"
* Spotlight on Advocacy: The IMF's 2011 Public Policy Agenda